Skip to main content

Table 8 Change from Baseline in Weight (kg) and Odds Ratios of ≥7% Weight Gain

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO 0.20 [−0.59, 1.00] 0.65 [0.34, 0.96] 2.88 [2.40, 3.36] 1.17 [0.84, 1.49] 0.34 [− 0.22, 0.89]
1.67 [0.56, 3.92] ARI 0.44 [− 0.42, 1.30] 2.68 [1.76, 3.61] 0.96 [0.10, 1.83] 0.14 [−0.85, 1.11]
3.50 [1.26, 8.65] 2.67 [0.56, 8.41] CAR 2.24 [1.66, 2.80] 0.52 [0.07, 0.96] −0.31 [− 0.95, 0.33]
68.46 [15.56, 231.00] 52.56 [7.42, 205.90] 24.93 [3.35, 95.57] OLA −1.71 [−2.29, −1.13] −2.54 [−3.28, − 1.81]
3.46 [1.91, 5.92] 2.64 [0.74, 6.90] 1.26 [0.34, 3.13] 0.08 [0.01, 0.25] QUE −0.83 [− 1.48, − 0.18]
19.08 [0.66, 108.10] 14.68 [0.35, 83.24] 6.85 [0.16, 39.89] 0.43 [0.01, 2.56] 5.98 [0.18, 33.08] LUR
  1. Note: Weight Change results are on the top-right and numbers represent the mean change [95% credible interval]. ≥7% Weight Gain results are on the bottom-left and results give the odds ratio [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine